艾欧凡斯生物治疗 IOVA
$8.04 +$0.30 (+3.88%)
休市 · Nov 6, 8:20 pm ET · 最新盘后价 $8.05 +0.07%
开盘$8.10
昨收$7.74
当日区间$7.72 – $8.28
成交量12.96M
市值$3.72B
市盈率（TTM）–
股息率–
基本面
最新报告季度：Q2, ended Jun 2026
营收$99.31M+65.7% YoY
营业利润-$51.91M+54.4% YoY
净利润-$47.32M+57.6% YoY
摊薄每股收益-$0.11+66.7% YoY
自由现金流-$66.28M+11.5% YoY
经营现金流-$60.84M
营收，近8个季度
净利润，近8个季度
各季度摊薄每股收益
各季度自由现金流
年度营收
盈利能力与资产负债表
毛利率48.4%
营业利润率-91.1%
净利率-89.1%
净资产收益率-40.7%
资产收益率-31.8%
投入资本回报率-39.3%
流动比率4.35
负债/资产比率19.6%
现金及投资$110.77M
总负债$43.33M
净现金（净负债）$67.44M
营收构成
2026/Q2 季度
按业务线
利润表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 报告营业总收入 | $99.31M | $71.43M | $263.50M | $86.77M | $67.46M |
| 营业总收入 | $99.31M | $71.43M | $263.50M | $86.77M | $67.46M |
| 营业成本 | $43.60M | $42.50M | $173.18M | $43.11M | $38.48M |
| 毛利润 | $55.72M | $28.93M | $90.32M | $43.66M | $28.98M |
| 营业费用 | $107.62M | $109.98M | $488.53M | $117.12M | $118.74M |
| 销售及管理费用 | $39.27M | $38.95M | $152.32M | $36.40M | $34.56M |
| 研发费用 | $58.85M | $62.49M | $300.27M | $71.20M | $75.17M |
| 折旧、摊销与折耗 | $9.50M | $8.54M | $35.94M | $9.52M | $9.01M |
| -折旧与摊销 | $9.50M | $8.54M | $35.94M | $9.52M | $9.01M |
| 营业利润 | -$51.91M | -$81.04M | -$398.21M | -$73.46M | -$89.76M |
| 非经营性利息净收入（支出） | $3.22M | $1.33M | $10.31M | $1.74M | $1.24M |
| 非经营性利息收入 | $3.22M | $1.33M | $10.31M | $1.74M | $1.24M |
| 税前利润 | -$48.69M | -$79.71M | -$393.05M | -$71.72M | -$93.66M |
| 税费 | -$1.37M | -$665,000.00 | -$2.07M | $184,000.00 | -$2.41M |
| 净利润 | -$47.32M | -$79.05M | -$390.98M | -$71.90M | -$91.25M |
| 持续经营利润 | -$47.32M | -$79.05M | -$390.98M | -$71.90M | -$91.25M |
| 归属母公司净利润 | -$47.32M | -$79.05M | -$390.98M | -$71.90M | -$91.25M |
| 归属普通股股东净利润 | -$47.32M | -$79.05M | -$390.98M | -$71.90M | -$91.25M |
| 基本每股收益 | -$0.11 | -$0.19 | -$1.09 | -$0.18 | -$0.25 |
| 摊薄每股收益 | -$0.11 | -$0.19 | -$1.09 | -$0.18 | -$0.25 |
| 其他收入（支出） | – | – | -$5.14M | $0.00 | -$5.14M |
| 特殊收益（费用） | – | – | -$5.14M | $0.00 | -$5.14M |
| -减：重组及并购费用 | – | – | $5.14M | $0.00 | $5.14M |
资产负债表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 总资产 | $915.53M | $925.67M | $913.17M | $913.17M | $904.95M |
| 流动资产合计 | $464.26M | $466.50M | $442.69M | $442.69M | $429.09M |
| 现金及现金等价物与短期投资 | $110.77M | $313.44M | $296.98M | $296.98M | $300.80M |
| -现金及现金等价物 | $110.77M | $196.51M | $163.08M | $163.08M | $158.13M |
| -应收账款 | $102.12M | $81.76M | $82.45M | $82.45M | $66.76M |
| 存货 | $55.59M | $58.38M | $51.68M | $51.68M | $51.71M |
| 其他流动资产 | $408.67M | $12.93M | $11.58M | $11.58M | $9.82M |
| 非流动资产合计 | $451.27M | $459.16M | $470.48M | $470.48M | $475.86M |
| 商誉及其他无形资产 | $263.89M | $269.10M | $279.32M | $279.32M | $285.21M |
| -其他无形资产 | $263.89M | $269.10M | – | – | $285.21M |
| 其他非流动资产 | $187.38M | $14.28M | $14.15M | $14.15M | $15.24M |
| 负债合计 | $179.49M | $203.91M | $214.59M | $214.59M | $202.66M |
| 流动负债合计 | $106.85M | $129.42M | $138.36M | $138.36M | $125.79M |
| -应付账款 | $26.21M | $37.45M | $22.16M | $22.16M | $31.24M |
| 一年内应计费用 | $77.96M | $88.07M | $111.16M | $111.16M | $87.27M |
| -一年内到期融资租赁负债 | $2.67M | $2.90M | $4.04M | $4.04M | $6.28M |
| 非流动负债合计 | $72.64M | $74.49M | $76.23M | $76.23M | $76.88M |
| 长期债务及融资租赁负债 | $43.33M | $43.88M | $44.40M | $44.40M | $45.21M |
| -长期融资租赁负债 | $43.33M | $43.88M | $44.40M | $44.40M | $45.21M |
| 股东权益合计 | $736.05M | $721.75M | $698.58M | $698.58M | $702.29M |
| 股东权益 | $722.95M | $721.75M | $698.58M | $698.58M | $702.29M |
| 股本 | $2,000.00 | $20,000.00 | $19,000.00 | $19,000.00 | $18,000.00 |
| -优先股 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 | $2,000.00 |
| 资本公积 | $3.62B | $3.56B | $3.46B | $3.46B | $3.39B |
| 留存收益 | -$2.90B | -$2.85B | -$2.78B | -$2.78B | -$2.70B |
| -短期投资 | – | $116.94M | $133.90M | $133.90M | $142.67M |
| 应收款 | – | $81.76M | $82.45M | $82.45M | $66.76M |
| 固定资产净值 | – | $175.78M | $177.01M | $177.01M | $175.41M |
| -固定资产原值 | – | $228.15M | $225.78M | $225.78M | $220.74M |
| -累计折旧 | – | -$52.37M | -$48.77M | -$48.77M | -$45.32M |
| 应付款 | – | $37.45M | $22.16M | $22.16M | $31.24M |
| 短期债务及融资租赁负债 | – | $3.90M | $5.04M | $5.04M | $7.28M |
| -一年内到期债务 | – | $1.00M | $1.00M | $1.00M | $1.00M |
| 一年以上递延负债 | – | $30.61M | $31.83M | $31.83M | $31.67M |
| -普通股 | – | $18,000.00 | $17,000.00 | $17,000.00 | $16,000.00 |
| 不影响留存收益的损益 | – | $12.65M | $16.44M | $16.44M | $16.10M |
现金流量表
| 项目 | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| 经营活动现金流 | -$60.84M | -$72.07M | -$302.41M | -$52.57M | -$78.70M |
| 持续经营经营活动现金流净额 | -$60.84M | -$72.07M | -$302.41M | -$52.57M | -$78.70M |
| 持续经营净利润 | -$47.32M | -$79.05M | -$390.98M | -$71.90M | -$91.25M |
| 持续经营损益 | -$355,000.00 | $462,000.00 | -$194,000.00 | -$373,000.00 | $232,000.00 |
| 折旧、折耗与摊销 | $10.40M | $10.42M | $47.32M | $12.64M | $11.52M |
| 递延税款 | -$1.37M | -$665,000.00 | -$2.07M | $184,000.00 | -$2.41M |
| 营运资金变动 | -$35.83M | -$12.88M | -$24.27M | -$7.29M | -$8.37M |
| -应收款变动 | -$20.36M | $690,000.00 | -$13.11M | -$15.69M | -$6.82M |
| -存货变动 | -$177,000.00 | -$4.93M | -$14.21M | -$4.00M | -$3.02M |
| -预付资产变动 | $5.91M | -$1.47M | -$8.02M | -$661,000.00 | $2.78M |
| -应付账款及应计费用变动 | -$20.43M | -$5.15M | $21.98M | $15.96M | $1.11M |
| -其他流动负债变动 | -$773,000.00 | -$2.03M | -$10.90M | -$2.90M | -$2.41M |
| 投资活动现金流净额 | -$74.05M | $11.39M | $47.50M | $775,000.00 | $17.01M |
| 持续经营投资活动现金流净额 | -$74.05M | $11.39M | $47.50M | $775,000.00 | $17.01M |
| 固定资产购置及出售净额 | -$5.44M | -$6.61M | -$33.84M | -$9.32M | -$10.84M |
| 投资购置及出售净额 | -$68.61M | $18.00M | $81.33M | $10.10M | $27.86M |
| 筹资活动现金流 | $49.29M | $94.34M | $300.77M | $56.17M | $88.06M |
| 持续经营筹资活动现金流净额 | $49.29M | $94.34M | $300.77M | $56.17M | $88.06M |
| 普通股发行净额 | $49.57M | $98.51M | $306.31M | $55.78M | $88.52M |
| 股票期权行使所得 | $887,000.00 | $0.00 | $1.53M | $839,000.00 | $2,000.00 |
| 其他筹资费用净额 | -$1.17M | -$4.18M | -$7.06M | -$445,000.00 | -$466,000.00 |
| 期末现金余额 | $116.77M | $202.50M | $169.06M | $169.06M | $164.10M |
| 现金净变动 | -$85.60M | $33.66M | $45.86M | $4.38M | $26.37M |
| 期初现金余额 | $202.50M | $169.06M | $122.05M | $164.10M | $138.41M |
| 汇率变动影响 | -$124,000.00 | -$213,000.00 | $1.14M | $577,000.00 | -$680,000.00 |
| 自由现金流 | -$66.28M | -$78.68M | -$336.24M | -$61.89M | -$89.55M |
| 业务购买及出售净额 | – | – | $0.00 | $0.00 | – |
暂无评论——快来第一个聊聊 IOVA。